Roei David Mazor

Tumor-reactive antibodies evolve from non-binding and autoreactive precursors

Roei David Mazor, Nachum Nathan, Amit Gilboa et al. · Cell · 2022 · 162 citations · Full text

Life Sciences, Immunology, Oncology +14

ICAMs support B cell interactions with T follicular helper cells and promote clonal selection

Irina Zaretsky, Ofir Atrakchi, Roei David Mazor et al. · The Journal of Experimental Medicine · 2017 · 98 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers

Shelley Klompus, Sigal Leviatan, Thomas Vogl et al. · Science Immunology · 2021 · 51 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series

Roei David Mazor, Mirra Manevich-Mazor, Anat Kesler et al. · BMC Medicine · 2014 · 43 citations · Full text

Medicine, Internal Medicine, Pathology +9

TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer

Jonathan Zorea, Yair Motro, Roei David Mazor et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 38 citations · Full text

Life Sciences, Immunology, Oncology +17